Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Phase of Trial: Phase III
Latest Information Update: 16 May 2018
At a glance
- Drugs Travoprost (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 26 Apr 2018 Status changed from planning to recruiting.
- 19 Sep 2017 New trial record
- 14 Sep 2017 According to a Glaukos Corporation media release, the company expects to initiate this trial in early 2018.